TW202405180A - 用於將核酸遞送至視網膜細胞的腺相關病毒載體 - Google Patents

用於將核酸遞送至視網膜細胞的腺相關病毒載體 Download PDF

Info

Publication number
TW202405180A
TW202405180A TW112112171A TW112112171A TW202405180A TW 202405180 A TW202405180 A TW 202405180A TW 112112171 A TW112112171 A TW 112112171A TW 112112171 A TW112112171 A TW 112112171A TW 202405180 A TW202405180 A TW 202405180A
Authority
TW
Taiwan
Prior art keywords
polypeptide
amino acid
acid sequence
seq
vector
Prior art date
Application number
TW112112171A
Other languages
English (en)
Chinese (zh)
Inventor
莉亞 卡羅琳 伯恩
莫莉 Ｅ 約翰遜
威廉 理查德 斯塔弗
比爾吉 艾辛 奧茲特克
Original Assignee
高等教育聯邦系統 匹茲堡大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 高等教育聯邦系統 匹茲堡大學 filed Critical 高等教育聯邦系統 匹茲堡大學
Publication of TW202405180A publication Critical patent/TW202405180A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14145—Special targeting system for viral vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW112112171A 2022-03-30 2023-03-30 用於將核酸遞送至視網膜細胞的腺相關病毒載體 TW202405180A (zh)

Applications Claiming Priority (26)

Application Number Priority Date Filing Date Title
US202263325559P 2022-03-30 2022-03-30
US202263325542P 2022-03-30 2022-03-30
US202263325548P 2022-03-30 2022-03-30
US202263325550P 2022-03-30 2022-03-30
US202263325553P 2022-03-30 2022-03-30
US202263325543P 2022-03-30 2022-03-30
US202263325544P 2022-03-30 2022-03-30
US202263325558P 2022-03-30 2022-03-30
US202263325562P 2022-03-30 2022-03-30
US202263325551P 2022-03-30 2022-03-30
US202263325540P 2022-03-30 2022-03-30
US202263325541P 2022-03-30 2022-03-30
US202263325555P 2022-03-30 2022-03-30
US63/325,550 2022-03-30
US63/325,555 2022-03-30
US63/325,544 2022-03-30
US63/325,553 2022-03-30
US63/325,562 2022-03-30
US63/325,542 2022-03-30
US63/325,551 2022-03-30
US63/325,543 2022-03-30
US63/325,559 2022-03-30
US63/325,541 2022-03-30
US63/325,540 2022-03-30
US63/325,558 2022-03-30
US63/325,548 2022-03-30

Publications (1)

Publication Number Publication Date
TW202405180A true TW202405180A (zh) 2024-02-01

Family

ID=88203541

Family Applications (1)

Application Number Title Priority Date Filing Date
TW112112171A TW202405180A (zh) 2022-03-30 2023-03-30 用於將核酸遞送至視網膜細胞的腺相關病毒載體

Country Status (11)

Country Link
US (1) US20250327092A1 (https=)
EP (1) EP4499848A4 (https=)
JP (1) JP2025510975A (https=)
KR (1) KR20250006360A (https=)
CN (1) CN119213136A (https=)
AU (1) AU2023243048A1 (https=)
CA (1) CA3255255A1 (https=)
IL (1) IL316014A (https=)
MX (1) MX2024011963A (https=)
TW (1) TW202405180A (https=)
WO (1) WO2023192463A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025072688A2 (en) * 2023-09-27 2025-04-03 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Adeno-associated virus vectors for nucleic acid delivery to retinal cells, for nucleic acid delivery across retinal regions, or for nucleic acid delivery to retinal ganglion cells and/or retinal pigment epithelium cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105755044A (zh) * 2011-04-22 2016-07-13 加利福尼亚大学董事会 具有变异衣壳的腺相关病毒病毒体及其使用方法
CN110612353A (zh) * 2017-03-03 2019-12-24 加利福尼亚大学董事会 经由抑制性tRNAs和脱氨酶对突变进行RNA靶向
CA3053154A1 (en) * 2017-06-30 2019-01-03 The Regents Of The University Of California Adeno-associated virus virions with variant capsids and methods of use thereof
AU2019227910B2 (en) * 2018-02-28 2025-07-17 The Regents Of The University Of California A modular system for gene and protein delivery based on AAV
US20220348613A1 (en) * 2019-08-28 2022-11-03 University of Pittsburgh - of the Commonwealath System of Higher Ecucation Adeno-associated viruses and methods and materials for making and using adeno-associated viruses
US20220313722A1 (en) * 2019-09-09 2022-10-06 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods of restoring lysosomal function of retinal pigment epithelial cells by activation of tfeb

Also Published As

Publication number Publication date
WO2023192463A3 (en) 2023-12-21
MX2024011963A (es) 2024-11-08
CA3255255A1 (en) 2023-10-05
WO2023192463A2 (en) 2023-10-05
KR20250006360A (ko) 2025-01-10
CN119213136A (zh) 2024-12-27
EP4499848A4 (en) 2026-03-25
AU2023243048A1 (en) 2024-10-03
US20250327092A1 (en) 2025-10-23
IL316014A (en) 2024-11-01
JP2025510975A (ja) 2025-04-15
EP4499848A2 (en) 2025-02-05

Similar Documents

Publication Publication Date Title
CN117858891A (zh) 用于基因疗法的经修饰aav衣壳及其方法
CN111876432B (zh) 一组肝靶向新型腺相关病毒的获得及其应用
US20250213722A1 (en) Adeno-associated virus vectors for nucleic acid delivery to retinal ganglion cells and/or retinal pigment epithelium cells
JP2023504735A (ja) ヒトｍｅｃｐ２遺伝子を発現するように設計されたトランスジーンカセット
TW202400797A (zh) 腺相關病毒載體
US20250327092A1 (en) Adeno-associated virus vectors for nucleic acid delivery to retinal cells
US20250222135A1 (en) Adeno-associated virus vectors for nucleic acid delivery across retinal regions
WO2025072688A2 (en) Adeno-associated virus vectors for nucleic acid delivery to retinal cells, for nucleic acid delivery across retinal regions, or for nucleic acid delivery to retinal ganglion cells and/or retinal pigment epithelium cells
CA3239289A1 (en) Functional aav capsids for intravitreal administration
JP7624727B2 (ja) 合理的設計により増強された新規なａａｖウイルスによる網膜における高効率の形質導入および側方への広がり
WO2024102739A2 (en) Adeno-associated virus (aav) production
WO2025231336A1 (en) Adeno-associated virus vectors
WO2026039585A2 (en) Adeno-associated virus vectors
WO2026050107A1 (en) Adeno-associated virus vectors
WO2025072698A2 (en) Aav9 vectors and capsid polypeptides for use in treating cns disorders
US20230390367A1 (en) Genetic approach to suppress coronaviruses